Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00749216
Recruitment Status : Completed
First Posted : September 9, 2008
Last Update Posted : June 2, 2010
Information provided by:
Eli Lilly and Company

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2009
  Actual Study Completion Date : July 2009
  Certification/Extension First Submitted : May 27, 2010